Cigna Group
CI- Exchange
- NYSE
- Industry
- Hospital & Medical Service Plans
- SEC CIK
- 0001739940
In the last 90 days, Cigna Group insiders filed 0 open-market purchases and 2 sales; 1,707 institutions reported holding it in 13F filings for Q2 2026, worth $65.4B in total; Greenlight Capital is the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Nov 8, 2026, 10:57 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 5, 2026 | Jan 30, 2025 | Feb 2, 2024 | Feb 3, 2023 | Feb 3, 2022 |
| Revenue | $274.9B | $247.1B | $195.3B | $180.5B | $174.1B |
| Cost of revenue | $215.0B | $182.5B | $133.8B | $124.8B | $117.6B |
| Selling, general and administrative | $14.6B | $14.8B | $14.8B | $13.2B | $13.0B |
| Operating income | $9.20B | $9.42B | $8.54B | $8.41B | $7.93B |
| Interest expense | $1.40B | $1.50B | $1.40B | $1.30B | $1.30B |
| Income tax | $1.49B | $1.49B | $141.0M | $1.61B | $1.37B |
| Net income | $5.96B | $3.78B | $5.37B | $6.75B | $5.42B |
| EPS, basic | $22.33 | $12.25 | $17.57 | $21.54 | $15.87 |
| EPS, diluted | $22.18 | $12.12 | $17.39 | $21.30 | $15.73 |
| Weighted shares, diluted | 268.6M | 283.2M | 296.9M | 313.1M | 341.0M |
| Margins and growth | |||||
| Operating margin | 3.3% | 3.8% | 4.4% | 4.7% | 4.6% |
| Net margin | 2.2% | 1.5% | 2.8% | 3.7% | 3.1% |
| Revenue growth, year over year | +11.2% | +26.6% | +8.2% | +3.7% | +8.5% |
| Net income growth, year over year | +57.7% | −29.7% | −20.4% | +24.6% | −36.2% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 5, 2026 | Jan 30, 2025 | Feb 2, 2024 | Feb 3, 2023 | Feb 3, 2022 |
| Cash and equivalents | $7.68B | $7.55B | $7.82B | $5.92B | $5.08B |
| Short-term investments | $1.06B | $665.0M | $925.0M | $905.0M | $920.0M |
| Accounts receivable | $28.8B | $24.2B | $17.7B | $17.2B | $15.1B |
| Inventory | $7.34B | $6.69B | $5.64B | $4.78B | $3.72B |
| Total current assets | $47.8B | $48.9B | $37.4B | $30.1B | $36.1B |
| Property, plant and equipment | $3.65B | – | – | $3.77B | $3.69B |
| Goodwill | $44.9B | $44.4B | $44.3B | $45.8B | $45.8B |
| Intangible assets | $28.6B | $29.4B | $30.9B | $32.5B | $34.1B |
| Total assets | $157.9B | $155.9B | $152.8B | $143.9B | $154.9B |
| Accounts payable | $10.7B | $9.29B | $8.55B | $7.78B | $6.66B |
| Short-term debt | $592.0M | $3.04B | $2.77B | $2.99B | $2.54B |
| Total current liabilities | $56.3B | $58.0B | $48.7B | $41.2B | $43.6B |
| Total liabilities | $116.0B | $114.6B | $106.4B | $99.0B | $107.7B |
| Shareholders' equity | $41.9B | $41.2B | $46.2B | $44.9B | $47.1B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 5, 2026 | Jan 30, 2025 | Feb 2, 2024 | Feb 3, 2023 | Feb 3, 2022 |
| Operating cash flow | $9.60B | $10.4B | $11.8B | $8.66B | $7.19B |
| Depreciation and amortization | $2.77B | $2.77B | $3.04B | $2.94B | $2.92B |
| Stock-based compensation | $291.0M | $308.0M | $286.0M | $264.0M | $268.0M |
| Dividends paid | $1.61B | $1.57B | $1.45B | $1.38B | $1.34B |
| Share buybacks | $3.62B | $7.03B | $2.28B | $7.61B | $7.74B |
| Investing cash flow | -$4.41B | -$2.10B | -$5.17B | $3.10B | -$3.61B |
| Financing cash flow | -$6.42B | -$7.65B | -$4.29B | -$11.2B | -$8.21B |
| Net change in cash | -$1.20B | $594.0M | $2.36B | $428.0M | -$4.70B |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 30, 2026 | 263.5M | −1.4% | SEC |
| Jul 24, 2026 | 264.2M | −1.0% | SEC |
| Apr 24, 2026 | 264.5M | −1.0% | SEC |
| Jan 30, 2026 | 263.5M | −3.7% | SEC |
| Oct 24, 2025 | 267.1M | −4.0% | SEC |
| Jul 25, 2025 | 266.9M | −4.5% | SEC |
| Apr 25, 2025 | 267.1M | −6.0% | SEC |
| Jan 31, 2025 | 273.7M | −6.4% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.